The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 4, 2026 | Subramaniam Somu | Director | Disposed to issuer(D) | 3.3M | — | — |
| Mar 4, 2026 | Subramaniam Somu | Director | Disposed to issuer(D) | 40K | — | — |
| Mar 4, 2026 | Subramaniam Somu | Director | Disposed to issuer(D) | 33K | — | — |
| Mar 4, 2026 | Subramaniam Somu | Director | Disposed to issuer(D) | 16K | — | — |
| Mar 4, 2026 | Subramaniam Somu | Director | Disposed to issuer(D) | 20K | — | — |
| Mar 4, 2026 | Subramaniam Somu | Director | Disposed to issuer(D) | 22K | — | — |
| Mar 4, 2026 | Hulme Allison | Director | Disposed to issuer(D) | 20K | — | — |
| Mar 4, 2026 | Hulme Allison | Director | Disposed to issuer(D) | 16K | — | — |
| Mar 4, 2026 | Hulme Allison | Director | Disposed to issuer(D) | 40K | — | — |
| Mar 4, 2026 | Hulme Allison | Director | Disposed to issuer(D) | 33K | — | — |
| Mar 4, 2026 | Hulme Allison | Director | Disposed to issuer(D) | 20K | — | — |
| Mar 4, 2026 | Gujrathi Sheila | Director | Disposed to issuer(D) | 130K | — | — |
| Mar 4, 2026 | Gujrathi Sheila | Director | Disposed to issuer(D) | 662K | — | — |
| Mar 4, 2026 | Gujrathi Sheila | Director | Disposed to issuer(D) | 278K | — | — |
| Mar 4, 2026 | Gujrathi Sheila | Director | Disposed to issuer(D) | 80K | — | — |
| Mar 4, 2026 | Gujrathi Sheila | Director | Disposed to issuer(D) | 40K | — | — |
| Mar 4, 2026 | Gujrathi Sheila | Director | Disposed to issuer(D) | 33K | — | — |
| Mar 4, 2026 | Gujrathi Sheila | Director | Disposed to issuer(D) | 22K | — | — |
| Mar 4, 2026 | Gujrathi Sheila | Director | Disposed to issuer(D) | 16K | — | — |
| Mar 4, 2026 | Gonzales Roy | Senior VP, Finance | Disposed to issuer(D) | 35K | — | — |
| Mar 4, 2026 | Gonzales Roy | Senior VP, Finance | Disposed to issuer(D) | 38K | — | — |
| Mar 4, 2026 | Gonzales Roy | Senior VP, Finance | Disposed to issuer(D) | 13K | — | — |
| Mar 4, 2026 | Gonzales Roy | Senior VP, Finance | Disposed to issuer(D) | 70K | — | — |
| Mar 4, 2026 | White William Richard | Director | Disposed to issuer(D) | 20K | — | — |
| Mar 4, 2026 | White William Richard | Director | Disposed to issuer(D) | 119K | — | — |
| Mar 4, 2026 | White William Richard | Director | Disposed to issuer(D) | 22K | — | — |
| Mar 4, 2026 | White William Richard | Director | Disposed to issuer(D) | 16K | — | — |
| Mar 4, 2026 | White William Richard | Director | Disposed to issuer(D) | 33K | — | — |
| Mar 4, 2026 | White William Richard | Director | Disposed to issuer(D) | 40K | — | — |
| Mar 4, 2026 | Cadoret-Manier Onaiza | Director | Disposed to issuer(D) | 33K | — | — |
| Mar 4, 2026 | Cadoret-Manier Onaiza | Director | Disposed to issuer(D) | 40K | — | — |
| Mar 4, 2026 | Cadoret-Manier Onaiza | Director | Disposed to issuer(D) | 20K | — | — |
| Mar 4, 2026 | Cadoret-Manier Onaiza | Director | Disposed to issuer(D) | 16K | — | — |
| Mar 4, 2026 | Cadoret-Manier Onaiza | Director | Disposed to issuer(D) | 20K | — | — |
| Mar 4, 2026 | Moore Matthew Richard | Chief Operating Officer | Disposed to issuer(D) | 320K | — | — |
| Mar 4, 2026 | Moore Matthew Richard | Chief Operating Officer | Disposed to issuer(D) | 145K | — | — |
| Mar 4, 2026 | Nuss John | CHIEF SCIENTIFIC OFFICER | Disposed to issuer(D) | 489K | — | — |
| Mar 4, 2026 | Nuss John | CHIEF SCIENTIFIC OFFICER | Disposed to issuer(D) | 140K | — | — |
| Mar 4, 2026 | Nuss John | CHIEF SCIENTIFIC OFFICER | Disposed to issuer(D) | 125K | — | — |
| Mar 4, 2026 | Nuss John | CHIEF SCIENTIFIC OFFICER | Disposed to issuer(D) | 181K | — | — |
| Mar 4, 2026 | Nuss John | CHIEF SCIENTIFIC OFFICER | Disposed to issuer(D) | 109K | — | — |
| Mar 4, 2026 | Nuss John | CHIEF SCIENTIFIC OFFICER | Disposed to issuer(D) | 415K | — | — |
| Mar 4, 2026 | Nuss John | CHIEF SCIENTIFIC OFFICER | Disposed to issuer(D) | 9K | — | — |
| Mar 4, 2026 | Nuss John | CHIEF SCIENTIFIC OFFICER | Disposed to issuer(D) | 193K | — | — |
| Mar 4, 2026 | Nuss John | CHIEF SCIENTIFIC OFFICER | Disposed to issuer(D) | 145K | — | — |
| Mar 4, 2026 | Mohan Raju | CEO AND PRESIDENT, Director | Disposed to issuer(D) | 2.4M | — | — |
| Mar 4, 2026 | Mohan Raju | CEO AND PRESIDENT, Director | Disposed to issuer(D) | 24K | — | — |
| Mar 4, 2026 | Mohan Raju | CEO AND PRESIDENT, Director | Disposed to issuer(D) | 467K | — | — |
| Mar 4, 2026 | Mohan Raju | CEO AND PRESIDENT, Director | Disposed to issuer(D) | 284K | — | — |
| Mar 4, 2026 | Mohan Raju | CEO AND PRESIDENT, Director | Disposed to issuer(D) | 8K | — | — |
| Mar 4, 2026 | Mohan Raju | CEO AND PRESIDENT, Director | Disposed to issuer(D) | 700K | — | — |
| Mar 4, 2026 | Mohan Raju | CEO AND PRESIDENT, Director | Disposed to issuer(D) | 155K | — | — |
| Mar 4, 2026 | Mohan Raju | CEO AND PRESIDENT, Director | Disposed to issuer(D) | 474K | — | — |
| Mar 4, 2026 | Mohan Raju | CEO AND PRESIDENT, Director | Disposed to issuer(D) | 370K | — | — |
| Mar 4, 2026 | Mohan Raju | CEO AND PRESIDENT, Director | Disposed to issuer(D) | 335K | — | — |
| Mar 4, 2026 | Forman Mark S | Chief Medical Officer | Disposed to issuer(D) | 6K | — | — |
| Mar 4, 2026 | Forman Mark S | Chief Medical Officer | Disposed to issuer(D) | 85K | — | — |
| Mar 4, 2026 | Forman Mark S | Chief Medical Officer | Disposed to issuer(D) | 350K | — | — |
| Mar 4, 2026 | Gonzales Roy | Senior VP, Finance | Disposed to issuer(D) | 109K | — | — |
| Mar 4, 2026 | Gonzales Roy | Senior VP, Finance | Disposed to issuer(D) | 18K | — | — |
| Mar 4, 2026 | Gonzales Roy | Senior VP, Finance | Disposed to issuer(D) | 5K | — | — |
| Feb 27, 2026 | Subramaniam Somu | Director | Other(J) | 695K | — | $0 |
| Dec 18, 2025 | Nuss John | CHIEF SCIENTIFIC OFFICER | Sell(S) | 13K | $7.72 | $98K |
| Dec 18, 2025 | Mohan Raju | CEO AND PRESIDENT, Director | Sell(S) | 47K | $7.72 | $366K |
| Dec 17, 2025 | Nuss John | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 35K | — | $0 |
| Dec 17, 2025 | Nuss John | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 35K | — | $0 |
| Dec 17, 2025 | Mohan Raju | CEO AND PRESIDENT, Director | Option exercise(M) | 117K | — | $0 |
| Dec 17, 2025 | Mohan Raju | CEO AND PRESIDENT, Director | Option exercise(M) | 117K | — | $0 |
| Nov 17, 2025 | Gonzales Roy | Senior VP, Finance | Grant(A) | 2K | $1.03 | $2K |
| Nov 17, 2025 | Forman Mark S | Chief Medical Officer | Grant(A) | 3K | $1.03 | $3K |
| Jun 5, 2025 | Gujrathi Sheila | Director | Grant(A) | 40K | — | $0 |
| Jun 5, 2025 | White William Richard | Director | Grant(A) | 40K | — | $0 |
| Jun 5, 2025 | Subramaniam Somu | Director | Grant(A) | 40K | — | $0 |
| Jun 5, 2025 | Hulme Allison | Director | Grant(A) | 40K | — | $0 |
| Jun 5, 2025 | Cadoret-Manier Onaiza | Director | Grant(A) | 40K | — | $0 |
| May 15, 2025 | Forman Mark S | Chief Medical Officer | Grant(A) | 3K | $1.03 | $3K |
| May 15, 2025 | Gonzales Roy | Senior VP, Finance | Grant(A) | 2K | $1.03 | $2K |
| Apr 2, 2025 | Nuss John | CHIEF SCIENTIFIC OFFICER | Sell(S) | 2K | $1.07 | $2K |
| Mar 28, 2025 | Subramaniam Somu | Director | Other(J) | 1.3M | — | $0 |
| Mar 28, 2025 | Nuss John | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 5K | — | $0 |
| Mar 28, 2025 | Nuss John | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 5K | — | $0 |
| Mar 28, 2025 | Mohan Raju | CEO AND PRESIDENT, Director | Option exercise(M) | 12K | — | $0 |
| Mar 28, 2025 | Mohan Raju | CEO AND PRESIDENT, Director | Option exercise(M) | 12K | — | $0 |
| Mar 10, 2025 | Subramaniam Somu | Director | Other(J) | 1.7M | — | $0 |
| Jan 2, 2025 | Forman Mark S | Chief Medical Officer | Grant(A) | 85K | — | $0 |
| Jan 2, 2025 | Gonzales Roy | Senior VP, Finance | Grant(A) | 109K | — | $0 |
| Jan 2, 2025 | Gonzales Roy | Senior VP, Finance | Grant(A) | 18K | — | $0 |
| Jan 2, 2025 | Moore Matthew Richard | Chief Operating Officer | Grant(A) | 145K | — | $0 |
| Jan 2, 2025 | Mohan Raju | CEO AND PRESIDENT, Director | Grant(A) | 700K | — | $0 |
| Jan 2, 2025 | Nuss John | CHIEF SCIENTIFIC OFFICER | Grant(A) | 170K | — | $0 |
| Jan 2, 2025 | Nuss John | CHIEF SCIENTIFIC OFFICER | Grant(A) | 245K | — | $0 |
| Dec 27, 2024 | Nuss John | CHIEF SCIENTIFIC OFFICER | Sell(S) | 21K | $2.36 | $50K |
| Dec 23, 2024 | Gujrathi Sheila | Director | Buy(P) | 130K | $2.31 | $300K |
| Dec 19, 2024 | Nuss John | CHIEF SCIENTIFIC OFFICER | Sell(S) | 13K | $2.26 | $30K |
| Dec 17, 2024 | Mohan Raju | CEO AND PRESIDENT, Director | Option exercise(M) | 117K | — | $0 |
| Dec 17, 2024 | Mohan Raju | CEO AND PRESIDENT, Director | Option exercise(M) | 117K | — | $0 |
| Dec 17, 2024 | Nuss John | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 35K | — | $0 |
| Dec 17, 2024 | Nuss John | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 35K | — | $0 |
| Dec 10, 2024 | Nuss John | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 5K | $0.20 | $1K |
| Dec 10, 2024 | Nuss John | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 194K | $0.20 | $39K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).